BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10340642)

  • 1. Growth and bone mineral density in a child with X-linked hypophosphatemic rickets: early response to treatment.
    Sugiyama T; Tanaka H; Kawai S
    J Bone Miner Metab; 1999; 17(2):137-40. PubMed ID: 10340642
    [No Abstract]   [Full Text] [Related]  

  • 2. Calcium metabolism and growth during early treatment of children with X-linked hypophosphataemic rickets.
    Kruse K; Hinkel GK; Griefahn B
    Eur J Pediatr; 1998 Nov; 157(11):894-900. PubMed ID: 9835432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal hypophosphatemic rickets.
    Hanna JD; Chan JC
    Curr Ther Endocrinol Metab; 1994; 5():499-503. PubMed ID: 7704781
    [No Abstract]   [Full Text] [Related]  

  • 4. Growth in children with X-linked hypophosphataemic rickets.
    Verge CF; Cowell CT; Howard NJ; Donaghue KC; Silink M
    Acta Paediatr Suppl; 1993 Mar; 388():70-5; discussion 76. PubMed ID: 8329834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypophosphatemic rickets presenting as recurring pedal stress fractures in a middle-aged woman.
    Linde R; Saxena A; Feldman D
    J Foot Ankle Surg; 2001; 40(2):101-4. PubMed ID: 11324665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal hypophosphatemic rickets - a review.
    Chan JC
    Int J Pediatr Nephrol; 1982 Dec; 3(4):305-10. PubMed ID: 6762360
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term growth hormone treatment in children with renal hypophosphatemic rickets: effects on growth, mineral metabolism, and bone density.
    Saggese G; Baroncelli GI; Bertelloni S; Perri G
    J Pediatr; 1995 Sep; 127(3):395-402. PubMed ID: 7658269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of growth hormone treatment on final height, phosphate metabolism, and bone mineral density in children with X-linked hypophosphatemic rickets.
    Baroncelli GI; Bertelloni S; Ceccarelli C; Saggese G
    J Pediatr; 2001 Feb; 138(2):236-43. PubMed ID: 11174622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial hypophosphatemic rickets: bone mass measurements in children following therapy with calcitriol and supplemental phosphate.
    Block JE; Piel CF; Selvidge R; Genant HK
    Calcif Tissue Int; 1989 Feb; 44(2):86-92. PubMed ID: 2492895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of therapy in X-linked hypophosphatemic rickets.
    Verge CF; Lam A; Simpson JM; Cowell CT; Howard NJ; Silink M
    N Engl J Med; 1991 Dec; 325(26):1843-8. PubMed ID: 1660098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone therapy in hypophosphatemic rickets.
    Wilson DM; Lee PD; Morris AH; Reiter EO; Gertner JM; Marcus R; Quarmby VE; Rosenfeld RG
    Am J Dis Child; 1991 Oct; 145(10):1165-70. PubMed ID: 1928011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. X-linked hypophosphatemic rickets: a study (with literature review) of linear growth response to calcitriol and phosphate therapy.
    Petersen DJ; Boniface AM; Schranck FW; Rupich RC; Whyte MP
    J Bone Miner Res; 1992 Jun; 7(6):583-97. PubMed ID: 1414477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Growth hormone treatment of familial hypophosphatemic rickets].
    Saggese G; Baroncelli GI; Barsanti S
    Arch Pediatr; 1998; 5 Suppl 4():360S-363S. PubMed ID: 9853084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of renal phosphate wasting in a child with autosomal dominant hypophosphatemic rickets caused by a FGF23 mutation.
    Kruse K; Woelfel D; Strom TM
    Horm Res; 2001; 55(6):305-8. PubMed ID: 11805436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term influence of calcitriol (1,25-dihydroxyvitamin D) and supplemental phosphate in X-linked hypophosphatemic rickets.
    Chesney RW; Mazess RB; Rose P; Hamstra AJ; DeLuca HF; Breed AL
    Pediatrics; 1983 Apr; 71(4):559-67. PubMed ID: 6300745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Healing of bone disease in X-linked hypophosphatemic rickets/osteomalacia. Induction and maintenance with phosphorus and calcitriol.
    Harrell RM; Lyles KW; Harrelson JM; Friedman NE; Drezner MK
    J Clin Invest; 1985 Jun; 75(6):1858-68. PubMed ID: 3839245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone mineral density of the spine and radius shaft in children with X-linked hypophosphatemic rickets (XLH).
    Oliveri MB; Cassinelli H; Bergadá C; Mautalen CA
    Bone Miner; 1991 Feb; 12(2):91-100. PubMed ID: 2015415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intramyocellular phosphate metabolism in X-linked hypophosphatemic rickets.
    Clarke GD; Kainer G; Conway WF; Chan JC
    J Pediatr; 1990 Feb; 116(2):288-92. PubMed ID: 2299505
    [No Abstract]   [Full Text] [Related]  

  • 19. Short- and long-term outcome of patients with pseudo-vitamin D deficiency rickets treated with calcitriol.
    Edouard T; Alos N; Chabot G; Roughley P; Glorieux FH; Rauch F
    J Clin Endocrinol Metab; 2011 Jan; 96(1):82-9. PubMed ID: 20926527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of calcitriol and phosphorus therapy on the growth of patients with X-linked hypophosphatemia.
    Friedman NE; Lobaugh B; Drezner MK
    J Clin Endocrinol Metab; 1993 Apr; 76(4):839-44. PubMed ID: 8473393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.